/
Login
Analysis Scores
Damodaran ?
55/100
Dalio Risk ?
59/100
Piotroski ?
4/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
$63.3
Pahalı
Active Metric?
4/4
Confidence?
72%
Valuation
Potential?
-5.5%
ROIC ?
21.5%
DCF Value ?
283.77
Debt Cycle?
Contraction
Data
Data ?
11329
1981-09-22 → 2026-09-03
Risk Analysis (VaR)
Orta
252 days
Annual Volatility ?
%25.3
VaR 95% ?
%2.71
daily max loss
VaR 99% ?
%3.79
daily max loss
CVaR 95% ?
%3.11
expected loss (tail)
Max Drawdown ?
%29.7
11.09.2025 → 15.05.2026
Skewness ?
0.34
Parametrik%2.71
Historik%2.41
Cornish-Fisher%2.51
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Downtrend
Price (318.51), TRAMA-99 line's %9.4 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 318.51
TRAMA: 351.3821
Difference: %-9.4
Profitability
Net Profit Margin
%8.7
Net profit margin %8.7 — positive but low. Compared to previous quarter -1.3 point decrease.
ROE – Özkaynak Getirisi (TTM)
%31.6
ROE %31.6 — high return on equity.
EBITDA Margin
%15.5
EBITDA margin %15.5 — good operational performance.
Gross Profit Margin
%33.4
Gross profit per revenue %33.4. Evaluate relative to sector.
Free Cash Flow Margin (TTM)
%8.2
TTM Free Cash Flow is %8.2'i. Moderate FCF — capex constraining operational profit.
Valuation
P/E Ratio
19.6x
Sector: 29.6x
F/K 19.6x — sector median's (29.6x) %34 below. Attractive for value investing.
P/B Ratio
26.31x
Sector: 4.58x
PD/DD 26.31x — sector median's %474 above. Expensive book value.
EV/EBITDA
14.9x
Sector: 15.6x
EV/EBITDA 14.9x — sector median (15.6x) in line.
Indebtedness
Current Ratio
1.05x
Current ratio 1.05x — borderline, attention required.
Net Debt / EBITDA
2.5x
Net Borç/EBITDA 2.5x — manageable debt level.
Debt / Equity
5.40x
Borç/Özkaynak 5.40x — very high leverage.
Interest Coverage
10.7x
Interest coverage 10.7x — very wide margin for paying interest expenses.
Growth
No balance sheet data
Score Explanations
Lothien Robustness
56/100
Good robustness (56/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
-5.5%
Minus %5.5 expected value (302.07) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %72.
Components: PE target: 448.73 | P/B target: 79.88 | EV/EBITDA target: 335.78 | DCF target: 283.77
Damodaran Valuation
55/100
Moderate Damodaran score (55/100). ROIC (%21.5) – WACC (%8.8) farkı +12.6 baz puan. Value creation capacity limited.
Moderate
Dalio Risk Analysis
59/100
Moderate debt risk (59/100). Interest coverage ratio 10.7x — strong. Borç/EBITDA 2.5x — manageable.
Leverage: 25/100 | Debt Service: 76/100 | Quality: 93/100
ROIC – Sermaye Getirisi
%21.5
ROIC (%21.5) cost of capital 12.6 puan aşıyor → company creates value.
WACC: %8.8
DCF Discounted Cash Flow
283.77
DCF (283.77) current price %11.2 below — cash flows do not support current price.
Current price: 319.52
Debt Cycle Phase
Contraction
High debt service + falling revenues. Balance sheet under pressure.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
$63.3
Güncel fiyat Graham valuenin %80.2 üzerinde ($63.3) — Expensive by Graham.
Expensive
⚖️ Sector Comparison
P/E Ratio
19.6x
vs 29.6x
Sector mediannın %34 below — cheap
P/B Ratio
26.31x
vs 4.58x
Compared to sector %474 more expensive (by book value)
EV/EBITDA
14.9x
vs 15.6x
Compared to sector %5 lower EV/EBITDA
ROIC vs WACC
%21.5
vs %8.8 WACC
ROIC 12.6 baz puan exceeds cost of capital
Charts
Indicators
BB deviation
?
RSI thresholds
?
▲ içeriden alım ·
▼ içeriden satım ·
★ katalizör (haber-sezgisel) ·
■ 13D aktivist ·
■ 13G pasif
— SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
İçeriden Alım-Satım Akışı
Kim aldı, kim sattı, ne kadar
HD — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.